A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone
Completed · Phase 3 · Has a placebo group
Conditions studied: Carcinoma, Non-Small Cell Lung
In brief
This study will test whether treatment with erlotinib plus SU011248 is better than erlotinib alone in patients with advanced/metastatic lung cancer who have received previous treatment with a platinum-based regimen.
Key facts
- Study ID
- NCT00457392
- Run by
- Pfizer
- People needed
- 960
- Starts
- 2007-07-01
- Expected to finish
- 2012-12-01
- Last updated by the study team
- 2013-10-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with locally advanced/metastatic non-small cell lung cancer
- Prior treatment with no more than 2 chemotherapy regimens including a platinum-based regimen
You may not qualify if…
- Prior treatment with any receptor tyrosine kinase inhibitors, VEGF inhibitor (with the exception of bevacizumab) or other angiogenesis inhibitors
- History of or known brain metastases
Where it is running
- Pfizer Investigational Site — Muscle Shoals, Alabama, United States
- Pfizer Investigational Site — Scottsdale, Arizona, United States
- Pfizer Investigational Site — Hot Springs, Arkansas, United States
- Pfizer Investigational Site — Antioch, California, United States
- Pfizer Investigational Site — Burbank, California, United States
- Pfizer Investigational Site — Downey, California, United States
- Pfizer Investigational Site — Fresno, California, United States
- Pfizer Investigational Site — La Jolla, California, United States
- Pfizer Investigational Site — La Jolla, California, United States
- Pfizer Investigational Site — Montebello, California, United States
- Pfizer Investigational Site — Pleasant Hill, California, United States
- Pfizer Investigational Site — San Diego, California, United States
- Pfizer Investigational Site — San Leandro, California, United States
- Pfizer Investigational Site — Whittier, California, United States
- Pfizer Investigational Site — Fairfield, Connecticut, United States
- Pfizer Investigational Site — Brooksville, Florida, United States
- Pfizer Investigational Site — Cocoa Beach, Florida, United States
- Pfizer Investigational Site — Fort Lauderdale, Florida, United States
- Pfizer Investigational Site — Merritt Island, Florida, United States
- Pfizer Investigational Site — Rockledge, Florida, United States
- Pfizer Investigational Site — Titusville, Florida, United States
- Pfizer Investigational Site — Athens, Georgia, United States
- Pfizer Investigational Site — Aurora, Illinois, United States
- Pfizer Investigational Site — Goshen, Indiana, United States
- Pfizer Investigational Site — Florence, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.